Company profile

Kuano

Providing innovative quantum and AI solutions for drug discovery and design.

Industry
Biotechnology Research
Employees
13
Headquarters
London
Office locations
1

Kuano company summary

Kuano is a company in the Biotechnology Research industry, headquartered in London. On LinkedIn the company has around 13 employees. Its listed specialties include Biotechnology, Artificial Intelligence, Quantum Chemistry, Covalent Inhibitors, Drug Discovery.

What technology does Kuano use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Kuano

Kuano is applying advanced computational methods to solve the hardest problems in therapeutic design, accelerating the path to life-changing medicines. Look at our evidence here: https://www.kuano.ai At the core of our offering is the Quantum Lens technology, a proprietary platform combining cutting-edge quantum physics with other high-end in silico techniques. Our technology is redefining how the industry understands complex binding and reactivity, enabling the exploration of molecular interactions beyond simplified views, incorporating quantum chemistry, AI, and system dynamics to achieve unparalleled precision. Our rigorous quantum-informed simulations blended with sophisticated AI-assisted workflows, are deployed by an expert team of physicists and drug hunters, working collaboratively with our partners to decipher complex modes of binding and explore completely untapped areas of chemical space. Whether the problem is selectivity, potency, novelty or unlocking something ‘undruggable’, we help partners design novel inhibitors with confidence, precision, and deeper scientific insight. Kuano’s unique platform can address many target types and modalities, from classical enzyme inhibitors to allosteric binders, and including covalent ligand reactivity prediction, moving beyond traditional limitations to analyze reactivity across different amino acid residues considering the full biological context. This results in Quantum Fingerprints that capture subtle electronic and energetic features missed by conventional analysis. Founded on the belief that next-generation computation is key to solving disease, Kuano works closely with a broad range of organisations, including leading global pharmaceutical and biotech organisations. We are committed to developing new products and researching novel technologies to dramatically improve the efficiency and productivity of the drug discovery process for our clients.

Specialties

BiotechnologyArtificial IntelligenceQuantum ChemistryCovalent InhibitorsDrug DiscoveryStructure Based Drug DesignMedicinal ChemistryMolecular Simulation

Where is Kuano located?

Kuano lists 1 location.

London, GB, GBHQ

Compare companies similar to Kuano

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Kuano
kuano.ai
Biotechnology Research13-London
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Kuano

What does Kuano do?

Kuano is applying advanced computational methods to solve the hardest problems in therapeutic design, accelerating the path to life-changing medicines. Look at our evidence here: https://www.kuano.ai At the core of our offering is the Quantum Lens technology, a proprietary platform combining cutting-edge quantum physics with other high-end in silico techniques. Our technology is redefining how the industry understands complex binding and reactivity, enabling the exploration of molecular interactions beyond simplified views, incorporating quantum chemistry, AI, and system dynamics to achieve unparalleled precision. Our rigorous quantum-informed simulations blended with sophisticated AI-assisted workflows, are deployed by an expert team of physicists and drug hunters, working collaboratively with our partners to decipher complex modes of binding and explore completely untapped areas of chemical space. Whether the problem is selectivity, potency, novelty or unlocking something ‘undruggable’, we help partners design novel inhibitors with confidence, precision, and deeper scientific insight. Kuano’s unique platform can address many target types and modalities, from classical enzyme inhibitors to allosteric binders, and including covalent ligand reactivity prediction, moving beyond traditional limitations to analyze reactivity across different amino acid residues considering the full biological context. This results in Quantum Fingerprints that capture subtle electronic and energetic features missed by conventional analysis. Founded on the belief that next-generation computation is key to solving disease, Kuano works closely with a broad range of organisations, including leading global pharmaceutical and biotech organisations. We are committed to developing new products and researching novel technologies to dramatically improve the efficiency and productivity of the drug discovery process for our clients.

How many employees does Kuano have?

Kuano has around 13 employees on LinkedIn.

Where is Kuano headquartered?

Kuano is headquartered in London.

Build a lead list from companies like Kuano

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.